Effectiveness and Safety of Combination Mifepristone/Misoprostol for Medical Abortion
Medical AbortionNational multi-center non interventional study aiming at investigating the effectiveness and safety of the combination mifepristone-misoprostol prescribed in Canada to women for medical termination of pregnancy at or before 63 days gestational age through a multi-center prospective non interventional study design.
null
Participation Requirements
-
Sex:
FEMALE -
Eligible Ages:
16 to 55
Participation Criteria
Inclusion criteria
Women who:
* request elective pregnancy termination in one of the sites participating into the study
* are prescribed mifepristone-misoprostol for this purpose
* provide informed consent to participate in the study.
Exclusion Criteria:
* Participant who is unable to understand or comply with Health Care Professional instructions or medical abortion regimen
* Participant who is unable or unwilling to provide written informed consent.
Study Location
Family Planning Clinic, Moncton City Hospital
Family Planning Clinic, Moncton City HospitalMoncton, New Brunswick
Canada
Contact Study Team
Women's College Hospital
Women's College HospitalToronto, Ontario
Canada
Contact Study Team
Manitoulin Health Centre
Manitoulin Health CentreMindemoya, Ontario
Canada
Contact Study Team
Centennial Primary Care
Centennial Primary CareKentville, Nova Scotia
Canada
Contact Study Team
Choice in Health Clinic
Choice in Health ClinicToronto, Ontario
Canada
Contact Study Team
Mud Creek Medical
Mud Creek MedicalNew Minas, Nova Scotia
Canada
Contact Study Team
- Study Sponsored By
- Linepharma International LTD
- Participants Required
- More Information
- Study ID:
NCT04905251